FP7H2020HORIZON
Certara UK Limited
- Country
- GBUnited Kingdom
- Defence projects
- 0
- Projects, all programmes
- 13
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 3,663,084
- Active
- 2008 to 2024
Projects
13 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| ERAMETEcosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines | HORIZON | 2024 | Associated partner | EUR 0 |
| RISK-HUNT3RRISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs | H2020 | 2021 | Participant | EUR 695,625 |
| DohART-NETPericonceptional Programming of Health Training Network | H2020 | 2019 | Partner | EUR 0 |
| TransQSTTranslational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 | H2020 | 2017 | Participant | EUR 484,600 |
| eTRANSAFEEnhacing TRANslational SAFEty Assessment through Integrative Knowledge Management | H2020 | 2017 | Participant | EUR 260,938 |
| OcuTherEducational Network in Ocular Drug Delivery and Therapeutics | H2020 | 2016 | Participant | EUR 273,288 |
| EU-ToxRiskAn Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century | H2020 | 2016 | Participant | EUR 665,765 |
| ORBITOOral biopharmaceutics tools | FP7 | 2012 | Participant | EUR 438,000 |
| TINN2Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates | FP7 | 2011 | Participant | EUR 50,000 |
| DDMOREDrug Disease Model Resources | FP7 | 2011 | Participant | EUR 145,000 |
| TAINTreatment of Adrenal Insufficiency in neonates- Development of a Hydrocortisone Preparation for the treatment of Adrenal Insufficiency in neonatesand infants | FP7 | 2011 | Participant | EUR 164,077 |
| NEUROBIDNeuroscience on Barriers in Development | FP7 | 2010 | Participant | EUR 240,592 |
| PREDICT-IVProfiling the toxicity of new drugs: a non animal-based approach integrating toxicodynamics and biokinetics | FP7 | 2008 | Participant | EUR 245,199 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.